Abstract:BACKGROUND: Although a number of proteins and genes relevant to schizophrenia have been identified in recent years, few are known about the exact metabolic pathway involved in this disease. Our previous proteomic study has revealed the energy metabolism abnormality in subchronic MK-801 treated rat, a well-established animal model for schizophrenia. This prompted us to further investigate metabolite levels in the same rat model to better delineate the metabolism dysfunctions and provide insights into the pathology of schizophrenia. METHODS: Metabolomics, a high-throughput investigatory strategy developed in recent years, can offer comprehensive metabolite-level insights that complement protein and genetic findings. In this study, we employed a nondestructive metabolomic approach (1H-MAS-NMR) to investigate the metabolic traits in cortex and hippocampus of MK-801 treated rats. Multivariate statistics and ingenuity pathways analyses (IPA) were applied in data processing. The result was further integrated with our previous proteomic findings by IPA analysis to obtain a systematic view on our observations. RESULTS: Clear distinctions between the MK-801 treated group and the control group in both cortex and hippocampus were found by OPLS-DA models (with R(2)X = 0.441, Q(2)Y = 0.413 and R(2)X = 0.698, Q(2)Y = 0.677, respectively). The change of a series of metabolites accounted for the separation, such as glutamate, glutamine, citrate and succinate. Most of these metabolites fell in a pathway characterized by down-regulated glutamate synthesis and disturbed Krebs cycle. IPA analysis further confirmed the involvement of energy metabolism abnormality induced by MK-801 treatment. CONCLUSIONS: Our metabolomics findings reveal systematic changes in pathways of glutamate metabolism and Krebs cycle in the MK-801 treated rats' cortex and hippocampus, which confirmed and improved our previous proteomic observation and served as a valuable reference to the etiology research of schizophrenia.

Effect of Acute and Chronic MK-801 Administration on Extracellular Glutamate and Ascorbic Acid Release in the Prefrontal Cortex of Freely Moving Mice on Line with Open-Field Behavior

Psychotomimetic Effects of Different Doses of MK-801 and the Underlying Mechanisms in a Selective Memory Impairment Model

Depletion of Microglia with PLX3397 Attenuates MK-801-induced Hyperactivity Associated with Regulating Inflammation-Related Genes in the Brain

Age-dependent Effects of (+)-MK801 Treatment on Glutamate Release and Metabolism in the Rat Medial Prefrontal Cortex

Effect of MK-801 and Ketamine on Hydroxyl Radical Generation in the Posterior Cingulate and Retrosplenial Cortex of Free-Moving Mice, As Determined by in Vivo Microdialysis

Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine.

The effects of repeated administrations of MK-801 on ERK and GSK-3beta signalling pathways in the rat frontal cortex

Enhanced interaction among ErbB4, PSD-95 and NMDAR by chronic MK-801 treatment is associated with behavioral abnormalities.

Aberrant Auditory Steady-State Response of Awake Mice After Single Application of the NMDA Receptor Antagonist MK-801 Into the Medial Geniculate Body

NMDA Receptor Hypofunction Induces Dysfunctions of Energy Metabolism and Semaphorin Signaling in Rats: a Synaptic Proteome Study.

Differential Effects of Systemic and Local Dizocilpine(mk-801) Administration on Dopamine and It's Metabolites Levels in Mice Prefrontal Cortex on Line with Open-Field Behavior

The Effects of Low-Dose MK-801 Treatment on Reference Memory,spatial Working Memory and Reversal Learning in Rats.

Subchronic MK-801 Treatment During Adolescence Induces Long-Term, Not Permanent, Excitatory-Inhibitory Imbalance in the Rat Hippocampus.

Bimodal Effects of MK-801 on Locomotion and Stereotypy in C57BL/6 Mice

Age-related Differential Sensitivity to MK-801-induced Locomotion and Stereotypy in C57BL/6 Mice.

Long-term effects of MK-801 administration during brain development on cognitive function and cerebral expression of NMDA receptors in rats

MK-801-exposure induces increased translation efficiency and mRNA hyperacetylation of Grin2a in the mouse prefrontal cortex

Metabolomic Analysis Reveals Metabolic Disturbance in the Cortex and Hippocampus of Subchronic Mk-801 Treated Rats

Effects of Neonatal MK-801 Exposure on Recognition Memory and Excitatory-Inhibitory Balance of Hippocampus in Adult Female Rats

Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats

Sustained Antidepressant Action of the N-methyl-D-aspartate Receptor Antagonist MK-801 in a Chronic Unpredictable Mild Stress Model.